Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Ordinary shares, par value 0.002 GBP per share
-
Shares outstanding
-
147M
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
66.9M
-
Shares change
-
+2.96M
-
Total reported value, excl. options
-
$258M
-
Value change
-
+$13.1M
-
Number of buys
-
16
-
Number of sells
-
-14
-
Price
-
$3.85
Significant Holders of Centessa Pharmaceuticals plc - Ordinary shares, par value 0.002 GBP per share (CNTA) as of Q1 2023
47 filings reported holding CNTA - Centessa Pharmaceuticals plc - Ordinary shares, par value 0.002 GBP per share as of Q1 2023.
Centessa Pharmaceuticals plc - Ordinary shares, par value 0.002 GBP per share (CNTA) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 66.9M shares
of 147M outstanding shares and own 45.4% of the company stock.
Largest 10 shareholders include Medicxi Ventures Management (Jersey) Ltd (20M shares), GENERAL ATLANTIC, L.P. (9.68M shares), BVF INC/IL (9.42M shares), EcoR1 Capital, LLC (5.62M shares), Vida Ventures Advisors, LLC (3.93M shares), OUP Management Co., LLC (2.94M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.31M shares), Point72 Asset Management, L.P. (1.78M shares), Samsara BioCapital, LLC (1.69M shares), and Boxer Capital, LLC (1.25M shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.